• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2001 Fiscal Year Final Research Report Summary

Cell surface engineering

Research Project

Project/Area Number 10145107
Research Category

Grant-in-Aid for Scientific Research on Priority Areas (A)

Allocation TypeSingle-year Grants
Research InstitutionKyoto University

Principal Investigator

TANAKA Atsuo  Graduate School of Engineering, Kyoto University, Professor, 大学院・工学研究科, 教授 (80026088)

Co-Investigator(Kenkyū-buntansha) AKIYOSHI Kazunari  Graduate School of Engineering, Kyoto University, Associate Professor, 大学院・工学研究科, 助教授 (90201285)
NAGAMUNE Teruyuki  Graduate School of Engineering, The University of Tokyo, Professor, 大学院・工学系研究科, 教授 (20124373)
Project Period (FY) 1998 – 2001
KeywordsCell surface / Arming yeast / Biomass / Anti-hen egg lysozyme / growth factor / Chimeric receptor / cell-surface saccharides / lipospme
Research Abstract

In cell surface, many recepter proteins are presented and the specific biomolecules are recognized by these recepter proteins. These mechanisms can be analyzed from chemical view points. To systemize the biotergeting, the cell sueface design was investigated. Dr. Tanaka studied the development of novel yeast cells armed with enzymes and functional proteins (glucoamylase, α-amylase, CM-cellulase, β-glucosidase, lipase, a histidine oligomer. green fluorescent protein, and its variants). The yeasts were constructed by a cell surface engiseering system of yeast Sacebaromyces cerevisiae, which can assimilate the redundant biomass or can display the vaccine protein. These surface-engineered yeast cells are termed as "Arming yeasts". "Cell surface engineering" will be capable of conferring novel additional abilities upon living cells and will herald a new era in the field of biotechnology. Dr. Nagamune Studied a way of changing the binding element of a growth factor so as to alter its specificity of specific ligand-receptor pairs. By joining these antibody variable domains, VH and VL, of anti-hen egg lysozyme (HEL) antibody HyHEL-10 to the cytoplasmic portion of erythropoietin receptor (EpoR), a chimeric receptor that could he activated by HEL was developed. When IL-3-dependent murine myeloid 32D cells were co-transfected with plasmids encoding VH-EpoR and VL-EpoR-IRES-EGFP, HEL induced selective expansion of the cell population with high expression level of EGFP. To expand the current approach, chimeric receptors whose cytoplasmic domain was replaced by that of gp 130 were developed. Dr. Akiyoshi studied the functions of cell-surface saccharides using liposomal displaying systems as model biological membrane. It was demonstrated that 1) function of gangliosides-conatining liposomes, 2) coating of phytylphosphate giant vesicles with a hydrophobized polysaccharide 3) dynamic morphological changes of cell-size liposomes in the presence of gangliosides.

  • Research Products

    (12 results)

All Other

All Publications (12 results)

  • [Publications] W.Zou 他: "Genetically controlled self-aggregation of cell-surface-engineered yeast responding to glucose concentration"Appl.Environ.Microbiol. 67. 2083-2087 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] S.Shibasaki 他: "Quantitative evaluation of the enhanced green fluorescent protein displayed on the cell surface of Saccharomyces cerevsiae by the fluorometric and confocal laser scanning microscopic analyses"Appl.Microbiol.Biotechnol. S5. 471-475 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kawahara, M 他: "Replacing factor-dependency with that for lysozyme : Affordable culture of IL-6-dependent hybridoma by transfecting artificial cell surface receptor"Biotechnol.Bioeng. 74. 416-423 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kawahara, M 他: "A growth signal with an artificially induced erythropoietin receptor-gp130 cytoplasmic domain heterodimer"J.Biochem. 130. 305-312 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] K.Ichinose 他: "Application to Cancer Chemotherapy of Supramolecular System"Biomedical Polymers and Polymer Therapeutics, KA/PP, New York. 33-36 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] H.Shiku 他: "A Novel Hydrophobized Polysacharide/Oncoprotein Complex Vaccine For Her2 Gene Expressing Cancer"Biomedical Polymers and Polymer Therapeutics, KA/PP, New York. 331-336 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] W. Zou et.al: "Genetically controlled self-aggregation of cell-surface-engineered yeast responding to glucose concentration"Appl. Environ. Microbiol. 67. 2083-2087 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] S. Shibasaki et.al: "Quantitative evaluation of the enhanced green fluorescent protein displayed on the cell surface of Saccharomyces cerevisiae by the fluorometric and confocal lasar scanning microscopic analyzes"Appl. Microbiol. Biotechnol. S5. 471-475 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kawahara, M et.al: "Replacing factor-dependency with that for lysozyme : Affordable culture of IL-6-dependent hybridoma by transfecting artificial cell surface receptor"Biotechnol. Bioeng. 74. 416-423 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kawahara, M et.al: "A growth signal with an artificially induced erythropoietin receptor-gpl30 cytoplasmic domain heterodimer"J. Biochem. 130. 305-312 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] K. Ichinose et.al: "Application to Cancer Chemotherapy of Supramolecular System"Biomedical Polymers and Polymer Therapeutics, KA/PP, New York. 33-36 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] H. Shiku et.al: "A Novel Hydrophobized Polysacharide/Oncoprotein Complex Vaccine For Her2 Gene Expressing Cancer"Biomedical Polymers and Polymer Therapeutics, KA/PP, New York. 331-336 (2001)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2004-04-14  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi